Dagco, Inc. Amgen Inc Transaction History

Dagco, Inc.

$225 Million
Q2 2024

A detailed history of Dagco, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Dagco, Inc. holds 480 shares of AMGN stock, worth $152,116. This represents 0.07% of its overall portfolio holdings.

Number of Shares

480

Previous 480 -0.0%

Holding current value

$152,116

Previous $136,000 9.56%

% of portfolio

0.07%

Previous 0.06%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$268.87 - $324.56 $102,170 - $123,332	380 Added 380.0%	480 $136,000
Q4 2023 Feb 15, 2024	BUY	$255.7 - $288.46 $25,570 - $28,845	100 New	100 $28,000
Q4 2021 Jan 24, 2022	SELL	$198.88 - $227.6 $204,846 - $234,428	-1,030 Closed	0 $0
Q3 2021 Nov 01, 2021	SELL	$212.27 - $248.7 $456,380 - $534,705	-2,150 Reduced 67.61%	1,030 $219,000
Q2 2021 Jul 12, 2021	SELL	$233.58 - $259.14 $114,454 - $126,978	-490 Reduced 13.35%	3,180 $775,000
Q1 2021 Apr 28, 2021	SELL	$221.91 - $258.6 $104,297 - $121,542	-470 Reduced 11.35%	3,670 $913,000
Q4 2020 Jan 28, 2021	SELL	$216.38 - $257.67 $10,819 - $12,883	-50 Reduced 1.19%	4,140 $952,000
Q2 2020 Jul 27, 2020	SELL	$197.81 - $242.74 $16,813 - $20,632	-85 Reduced 1.99%	4,190 $988,000
Q1 2020 Apr 30, 2020	SELL	$182.24 - $241.7 $43,737 - $58,008	-240 Reduced 5.32%	4,275 $867,000
Q4 2019 Feb 06, 2020	SELL	$189.21 - $243.2 $28,381 - $36,480	-150 Reduced 3.22%	4,515 $1.09 Million
Q3 2019 Oct 28, 2019	SELL	$174.11 - $208.62 $26,116 - $31,293	-150 Reduced 3.12%	4,665 $903,000
Q2 2019 Aug 08, 2019	SELL	$166.7 - $195.41 $12,502 - $14,655	-75 Reduced 1.53%	4,815 $887,000
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $61,495 - $69,319	-340 Reduced 6.5%	4,890 $929,000
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $933,032 - $1.09 Million	5,230 New	5,230 $1.02 Million

Others Institutions Holding AMGN

# of Institutions

3,087

Shares Held

417M

Call Options Held

7.19M

Put Options Held

6.13M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $170B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dagco, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Dagco, Inc. with notifications on news.

Account